» Articles » PMID: 15666443

Reproducibility of Urinary Cadmium, Alpha1-microglobulin, and Beta2-microglobulin Levels in Health Screening of the General Population

Overview
Date 2005 Jan 26
PMID 15666443
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The present study examined whether levels of cadmium, and alphal- and beta2-microglobulin in urine (Cd-U, ac-MG-U, and beta2-MG-U, respectively) were reproducible in urine samples collected from the same subjects on multiple occasions. For this purpose, two databases on background exposure to cadmium in Japan-one from study I between 2000 and 2001 and the other from study II in 2002-were revisited to find 231 apparently healthy, nonpregnant, nonlactating adult women who participated in both studies and thus had provided two urine samples. The databases contained information on Cd-U, alphal,-MG-U, and beta2-MG-U, creatinine (CR), and specific gravity (SG) as well as smoking and other lifestyle factors. Of the 231 women, 195 who had never smoked were selected for the present analysis. Cd-U as well as alpha1-MG-U were reproducible (e.g., with correlation coefficients [r] between study I and II results of 0.4 to 0.6) when measured on two occasions 9 to 10 months apart. The r values were lower for beta2-MG-U (r0.3). Exclusion of urine samples with inadequate urine density(i.e., CR <0.5 or >3.0 g/L or SG <1.010 or >1.030) resulted in substantial improvement of the agreements between the two measures (e.g., r = 0.6 to 0.7 for Cd-U and alpha1-MG-U). CR and SG correlated closely with each other, especially in low-density urine samples (r >0.9), and therefore the effects of CR and SG could not be evaluated separately. In the overall evaluation,single determination (i.e., without repeated urine sampling) of Cd-U and alpha1-MG-U should be acceptable, and it may also be acceptable for beta2-MG-U. Use of samples with adequate urine density rather than application of density correction to low-density urine samples in recommended.

Citing Articles

A State-of-the-Science Review on Metal Biomarkers.

Martinez-Morata I, Sobel M, Tellez-Plaza M, Navas-Acien A, Howe C, Sanchez T Curr Environ Health Rep. 2023; 10(3):215-249.

PMID: 37337116 PMC: 10822714. DOI: 10.1007/s40572-023-00402-x.


Urine and toenail cadmium levels in pregnant women: A reliability study.

White A, OBrien K, Jackson B, Karagas M Environ Int. 2018; 118:86-91.

PMID: 29857281 PMC: 6045451. DOI: 10.1016/j.envint.2018.05.030.


Is Urinary Cadmium a Biomarker of Long-term Exposure in Humans? A Review.

Vacchi-Suzzi C, Kruse D, Harrington J, Levine K, Meliker J Curr Environ Health Rep. 2016; 3(4):450-458.

PMID: 27696280 PMC: 5453507. DOI: 10.1007/s40572-016-0107-y.


Temporal variability of urinary cadmium in spot urine samples and first morning voids.

Vacchi-Suzzi C, Porucznik C, Cox K, Zhao Y, Ahn H, Harrington J J Expo Sci Environ Epidemiol. 2016; 27(3):306-312.

PMID: 27168395 PMC: 5461949. DOI: 10.1038/jes.2016.28.


Dietary Intake Estimates and Urinary Cadmium Levels in Danish Postmenopausal Women.

Vacchi-Suzzi C, Eriksen K, Levine K, McElroy J, Tjonneland A, Raaschou-Nielsen O PLoS One. 2015; 10(9):e0138784.

PMID: 26390122 PMC: 4577120. DOI: 10.1371/journal.pone.0138784.